Aslıhan DOĞRU -TDO- Stella Kyriakides, the health commissioner of the European Union (EU) Commission, held a press conference in Brussels on the EU's new type of coronavirus (Covid-19) treatment strategy.
"By October, we aim to develop and authorize 3 new treatments that have the potential to change the course of Covid-19," Kyriakides said in a statement.
Kyriakides stressed that vaccination alone is not enough to neutralize Covid-19 and that it is necessary to offer therapeutic solutions to citizens.
Kyriakides stated that there are 4 different Covid-19 vaccines approved and used by the EU and that only the antiviral drug Remdesivir is used for the treatment process, adding that Covid-19 treatment strategies aim to change this situation.
"By October, we aim to develop and authorize 3 new treatments that have the potential to change the course of Covid-19. We plan to complete 3 supply agreements for Covid-19 treatment by the end of the year," she said.